* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Download Intravenous Immunoglobulin in Autoimmune Neuromuscular
Survey
Document related concepts
Complement system wikipedia , lookup
Rheumatic fever wikipedia , lookup
Lymphopoiesis wikipedia , lookup
Immune system wikipedia , lookup
Innate immune system wikipedia , lookup
Adaptive immune system wikipedia , lookup
Monoclonal antibody wikipedia , lookup
Psychoneuroimmunology wikipedia , lookup
Cancer immunotherapy wikipedia , lookup
Polyclonal B cell response wikipedia , lookup
Adoptive cell transfer wikipedia , lookup
Hygiene hypothesis wikipedia , lookup
Myasthenia gravis wikipedia , lookup
X-linked severe combined immunodeficiency wikipedia , lookup
Sjögren syndrome wikipedia , lookup
Immunosuppressive drug wikipedia , lookup
Transcript
From: Intravenous Immunoglobulin in Autoimmune Neuromuscular Diseases JAMA. 2004;291(19):2367-2375. doi:10.1001/jama.291.19.2367 Figure Legend: Intravenous immunoglobulin (IVIG) modulates multiple immunologicevents (blue boxes) involved in the pathogenesis of autoimmune neuromusculardiseases. Diseases for which specific therapeutic actions of IVIG are supportedby experimental evidence are listed in each box. In autoimmune neuromusculardiseases, an antigen, through molecular mimicry, defective clonal deletion,or other mechanisms, triggers an immune response that results in loss of immunetolerance to self-antigens. Infused IVIG interferes with costimulatory moleculesinvolved in antigen presentation modulates subsequent immunologic events.These events, mediated by Copyrightand © 2004 American Medical Date of download: 5/14/2017 activation of B cells with production of autoantibodiesand by T cells, lead to tissue damage via complement activation, macrophage– Association. All rights reserved. Fcreceptor interaction, and cytotoxic T cells. Other possible therapeutic actionsof IVIG not shown in this illustration include From: Intravenous Immunoglobulin in Autoimmune Neuromuscular Diseases JAMA. 2004;291(19):2367-2375. doi:10.1001/jama.291.19.2367 Figure Legend: Muscle biopsy specimens from a patient with dermatomyositis who hadsubstantial clinical improvement after 3 infusions of intravenous immunoglobulin(IVIG) were stained with monoclonal antibodies to intercellular adhesion molecule1 (ICAM-1) using an immunoperoxidase technique. A, Before IVIG therapy, ICAM-1is strongly expressed on endothelial cells, infiltrating lymphocytes, andoccasional muscle fibers (brown chromogen). B, After therapy, ICAM-1 expressionis markedly suppressed, and the size of the muscle fibers is increased. Nucleiappear blue inCopyright both panels. (Counterstain: hematoxylin; original magnification×125). Photo © 2004 American Medical Date of download: 5/14/2017 Health. source: National Institutesof Association. All rights reserved.